Biolife Sciences (Biolife Sciences) Long-Term Debt : $0.42 Mil (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Long-Term Debt?

Biolife Sciences's Long-Term Debt for the quarter that ended in May. 2008 was $0.42 Mil.

Biolife Sciences's quarterly Long-Term Debt declined from Nov. 2007 ($0.21 Mil) to Feb. 2008 ($0.17 Mil) but then increased from Feb. 2008 ($0.17 Mil) to May. 2008 ($0.42 Mil).

Biolife Sciences's annual Long-Term Debt declined from Nov. 2005 ($1.25 Mil) to Nov. 2006 ($0.30 Mil) and declined from Nov. 2006 ($0.30 Mil) to Nov. 2007 ($0.21 Mil).

Biolife Sciences Long-Term Debt Historical Data

The historical data trend for Biolife Sciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Long-Term Debt Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Long-Term Debt

1.25

0.30

0.21

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Long-Term Debt	Get a 7-Day Free Trial										2.52	0.38	0.21	0.17	0.42

Biolife Sciences (OTCPK:BLFE) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Biolife Sciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020